Martingale Asset Management L P Supernus Pharmaceuticals, Inc. Transaction History
Martingale Asset Management L P
- $3.87 Billion
- Q1 2025
A detailed history of Martingale Asset Management L P transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 57,199 shares of SUPN stock, worth $1.84 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
57,199
Previous 44,592
28.27%
Holding current value
$1.84 Million
Previous $1.61 Million
16.19%
% of portfolio
0.05%
Previous 0.04%
Shares
21 transactions
Others Institutions Holding SUPN
# of Institutions
305Shares Held
60.8MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$334 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$198 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$167 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$93.4 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$86.8 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.72B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...